blank
blank

Slovenia joins ERDERA’s Joint Transnational Call for Proposals on Rare Disease Therapies

blank

We are delighted to announce that the Ministry of Health of the Republic of Slovenia (Ministrstvo za zdravje) has officially joined the funding organisations participating in the first Joint Transnational Call for Proposals on Rare Disease Therapies. This initiative is part of ERDERA’s ongoing commitment to advancing cutting-edge research in this critical area.

This collaboration represents a major milestone in strengthening international cooperation to address rare diseases through innovative therapeutic approaches. It also highlights an important advancement in promoting greater inclusion and participation of countries that have been underrepresented in funding calls, paving the way for more equitable research opportunities.

Updated call documents now available

We are pleased to announce that the updated documents for the JTC 2025 are now accessible on our website. These documents provide detailed information on eligibility, application guidelines, and evaluation criteria, ensuring a smooth and informed proposal submission process.

Key updates (as of 16 January 2025):

  • Call text: addition of Ministry of Health of the Republic of Slovenia (SI MoH), Slovenia, to funding organisations participating in the call and to underrepresented countries list.
  • Guidelines: changes in national guidelines for FCT, CIHR, RCN, BMBF, multinational PAO funding; addition of national guidelines for SI MoH, Slovenia.
  • Pre-proposal submission preview: removal of budget justification entries.
  • FAQ: additional Q&A.

For further details, access the updated call documents here.

Application timeline

The JTC 2025 will follow a two-stage submission process:

  • 13 February 2025: Pre-proposal submission deadline.
  • 9 July 2025: Full proposals submission deadline. Funding decisions are expected by December 2025.

Contact and stay updated

For more information, contact the Joint Call Secretariat at SelteneErkrankungen@dlr.de or reach out to the relevant national contact point.

Stay informed with the latest updates from ERDERA by regularly visiting our website, subscribing to our newsletter, and following us on social media.

News & Updates

You might also be interested in

EU Flags

European Commission opens call for evidence on future Joint Undertakings

Feedback is open until 14 July 2026, giving stakeholders an early opportunity to comment during the preparation of a likely legislative proposal for a Council regulation.
European Human Genetics Conference - Rotterdam, The Netherlands June 12-15, 2027

European Human Genetics Conference 2027

June 12 - June 15
The conference will take place in Rotterdam on 12–15 June 2027 and is planned as a hybrid event by the European Society of Human Genetics.
uropean Human Genetics Conference (ESHG) 2026

At ESHG 2026 in Gothenburg, ERDERA’s diagnostics work reviewed early progress and the next phase ahead

At the European Human Genetics Conference 2026 in Gothenburg, ERDERA’s Diagnostic Research Workstream reviewed progress, highlighted early results and used a major European genetics meeting to examine how advances in data sharing and genomic analysis may strengthen rare disease diagnosis across countries.
WODC Boston 2026

At World Orphan Drug Congress USA, ERDERA highlights how connected clinical research networks can make rare disease trials more feasible

Boston, 9–11 June 2026: ERDERA's Scientific Coordinator joined the World Orphan Drug Congress USA to set out how stronger clinical research networks can make rare disease trials more feasible across sites and borders.

ERDERA's

search form